This increase in mitochondrial metabolism in melanoma cells following CDK4/6 inhibition is partially fuelled by both glutamine metabolism and fatty acid oxidation pathways and is mediated by a p53 dependent pathway. The gene discussed is CDK4; the disease is melanoma.